First Tracks Biotherapeutics, Inc. Ordinary Shares TRAX
$34.13
+7.73%
at last close
Analyst Consensus
- Consensus Rating
- Buy (11 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $66.27
- Implied Upside
- +94.2%
- Price Target Range
- $31.00 – $100.00
- Analysts (12 mo)
- 11
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-13 | Canaccord GenuityEdward Nash |
Maintains | Buy | $50 → $60 |
| 2026-10-13 | Evercore ISI GroupGavin Clark-Gartner |
Maintains | Outperform | $65 → $70 |
| 2026-10-13 | Wells FargoDerek Archila |
Maintains | Overweight | $62 → $70 |
| 2026-09-30 | Canaccord GenuityEdward Nash |
Initiates coverage on | Buy | $50 |
| 2026-09-18 | Evercore ISI GroupGavin Clark-Gartner |
Initiates coverage on | Outperform | $65 |
| 2026-09-16 | GuggenheimYatin Suneja |
Initiates coverage on | Buy | $100 |
| 2026-09-03 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $57 |
| 2026-08-13 | BarclaysEtzer Darout |
Maintains | Overweight | $48 → $65 |
| 2026-08-13 | WedbushMartin Fan |
Maintains | Outperform | $60 → $70 |
| 2026-08-13 | Piper SandlerYasmeen Rahimi |
Maintains | Overweight | $54 → $95 |
| 2026-08-13 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $44 → $57 |
| 2026-08-10 | UBSMichael Yee |
Maintains | Buy | $45 → $65 |
| 2026-07-28 | WedbushMartin Fan |
Maintains | Outperform | $30 → $60 |
| 2026-07-28 | Wells FargoDerek Archila |
Maintains | Overweight | $30 → $55 |
| 2026-07-21 | BarclaysEtzer Darout |
Maintains | Overweight | $40 → $48 |
| 2026-07-10 | HC Wainwright & Co.Emily Bodnar |
Maintains | Buy | $30 → $44 |
| 2026-07-08 | HC Wainwright & Co.Emily Bodnar |
Reiterates | Buy | $30 |
| 2026-06-08 | Wells FargoDerek Archila |
Initiates coverage on | Overweight | $30 |
| 2026-05-04 | Piper SandlerYasmeen Rahimi |
Initiates coverage on | Overweight | $54 |
| 2026-04-28 | HC Wainwright & Co.Emily Bodnar |
Initiates coverage on | Buy | $30 |
| 2026-04-24 | Leerink PartnersDavid Risinger |
Initiates coverage on | Outperform | $46 |
| 2026-04-23 | JP MorganAnupam Rama |
Initiates coverage on | Overweight | $31 |
| 2026-04-22 | BarclaysEtzer Darout |
Initiates coverage on | Overweight | $40 |
| 2026-04-21 | UBSMichael Yee |
Initiates coverage on | Buy | $45 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $34.13
- Market Cap
- $1.13 billion
- 52-Week Range
- $14.72 – $49.91
- Average Volume
- 1.00 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.